Global Syringes and Injectable Drugs Packaging Market Size - By Product Type, By Material Type and By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
Global Syringes and Injectable Drugs Packaging Market Size - By Product Type, By Material Type and By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Mar-2026 | Report ID: PACK2671 | Pages: 1 - 135 | Formats*: |
| Category : Packaging | |||
According to SPER Market Research, the Global Syringes and Injectable Drugs Packaging Market is estimated to reach USD 109.04 billion by 2034 with a CAGR 13.55%.
Introduction and Overview
The report includes an in-depth analysis of the Global Syringes and Injectable Drugs Packaging Market, including market size and trends, product mix, Applications, and supplier analysis.
The global syringes and injectable drugs packaging market, valued at USD 30.6 billion in 2024, projects strong growth at a 13.55% CAGR from 2025 to 2034. Rising demand for injectable treatments fuels this trend, driven by increasing infectious diseases such as malaria and tuberculosis, plus expanding vaccination programs. Packaging innovations prioritize sterility and contamination prevention for safe direct bloodstream delivery.
By Product Type:
The Global syringes and injectable drugs packaging sector drives healthcare innovation by ensuring sterile, reliable delivery of vital medications worldwide. Syringes lead as the dominant category, fuelled by their essential role in vaccinations, emergency care, and patient self-administration, alongside growing preferences for safety-enhanced designs that curb contamination risks. Injectable drugs packaging complements this through specialized formats like vials and cartridges, prioritizing drug stability and usability across hospitals, clinics, and home settings. Regulatory emphasis on tamper-proof solutions and material advancements further bolsters this dynamic field, meeting diverse end-user needs effectively.
By Material Type:
In the global market for syringes and injectable drugs packaging, plastic stands out as the dominant material, favoured for its adaptability, strength, and ease of shaping into secure, user-friendly formats like prefilled syringes. Glass plays a vital role in preserving sensitive formulations, while other materials address niche needs for enhanced protection. Growth stems from expanding injectable therapies, stricter safety standards, and shifts toward single-dose solutions that minimize contamination. Innovations focus on sustainable options and advanced barriers, supporting broader healthcare demands across hospitals, clinics, and home settings without compromising efficacy or sterility.
By End Use:
In the Global syringes and injectable drugs packaging landscape, hospitals and clinics lead as the primary end-use category, fuelled by substantial needs for secure, sterile solutions amid intensive medical activities like procedures and patient care. Ambulatory surgical centres prioritize compact, efficient packaging for outpatient operations, while pharmaceutical and biotechnology firms focus on specialized designs to preserve drug integrity during production and distribution. Home healthcare settings demand user-friendly, tamper-evident options to support self-administration and remote monitoring. Vaccination centres emphasize scalable, hygienic packaging to facilitate widespread immunization efforts.
Regional Insights:
North America dominates the syringes and injectable drugs packaging sector due to its robust pharmaceutical and biologics base, advanced healthcare systems, and rising demand for safe, compliant prefilled syringes using innovative materials. In the U.S., escalating chronic conditions drive needs for protective packaging to prevent contamination. Canada emphasizes sustainable, recyclable options amid pharmaceutical shifts for patient safety. Europe follows closely, fuelled by biopharma expansion and demand for sterile, high-barrier solutions like coated glass and cyclic olefin polymers. Asia Pacific surges with sustainable transitions, biologics growth, and chronic disease prevalence, led by China, India, and Japan. Latin America and Middle East & Africa grow via disease rises and safety-focused packaging.
Market Competitive Landscape:
The Global Syringes and Injectable Drugs Packaging Market is highly consolidated Some of the market key players are BD, AptarGroup Inc., Bormioli Pharma S.p.A., Catalent Inc, Credence MedSystems Inc., DWK Life Sciences, Gerresheimer, J. Penner Corporation, Laboratorios Farmaceuticos Rovi S.A., Nipro Europe Group Companies, Schott AG, SGD Pharma, Shandong Province Medicinal Glass Co. Ltd., Stevanato Group, Terumo Europe NV, USIN Advance Co. Ltd., Weigao Group, West Pharmaceutical Services Inc.
Recent Developments:
In October 2024, SCHOTT Pharma teamed up with Schreiner MediPharm and Körber Pharma to introduce an innovative packaging solution for prefilled syringes, aimed at cutting down on plastic use and overall packaging waste.
In June 2024, Sharp Services revealed plans to expand its Pennsylvania facility, boosting production capacity for secondary packaging of sterile injectables.
Scope of the report:
| Report Metric | Details |
|---|---|
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product Type, By Material Type, By End Use |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | BD, AptarGroup Inc., Bormioli Pharma S.p.A., Catalent Inc, Credence MedSystems Inc., DWK Life Sciences, Gerresheimer, J. Penner Corporation, Laboratorios Farmaceuticos Rovi S.A., Nipro Europe Group Companies, Schott AG, SGD Pharma, Shandong Province Medicinal Glass Co. Ltd., Stevanato Group, Terumo Europe NV, USIN Advance Co. Ltd., Weigao Group, West Pharmaceutical Services Inc. |
Key Topics Covered in the Report
- Global Syringes and Injectable Drugs Packaging Market Size (FY’2021-FY’2034)
- Overview of Global Syringes and Injectable Drugs Packaging Market
- Segmentation of Global Syringes and Injectable Drugs Packaging Market by Product Type (Syringes, Injectable drugs packaging)
- Segmentation of Global Syringes and Injectable Drugs Packaging Market by Material Type (Plastic, Glass, Others)
- Segmentation of Global Syringes and Injectable Drugs Packaging Market by End Use (Hospitals and clinics, Ambulatory surgical centres, Pharmaceutical & biotechnology companies, home healthcare settings, Vaccination centres)
- Statistical Snap of Global Syringes and Injectable Drugs Packaging Market
- Expansion Analysis of Global Syringes and Injectable Drugs Packaging Market
- Problems and Obstacles in Global Syringes and Injectable Drugs Packaging Market
- Competitive Landscape in the Global Syringes and Injectable Drugs Packaging Market
- Details on Current Investment in Global Syringes and Injectable Drugs Packaging Market
- Competitive Analysis of Global Syringes and Injectable Drugs Packaging Market
- Prominent Players in the Global Syringes and Injectable Drugs Packaging Market
- SWOT Analysis of Global Syringes and Injectable Drugs Packaging Market
- Global Syringes and Injectable Drugs Packaging Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1 Scope of the report1.2 Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary Data2.1.2 Primary Data2.1.3 SPER’s internal Database2.1.4 Primary insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1 Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers4.1.2 Restraints4.1.3 Opportunities4.1.4 Challenges
5. Market variable and outlook
5.1 SWOT Analysis
5.1.1 Strengths5.1.2 Weaknesses5.1.3 Opportunities5.1.4 Threats
5.2 PESTEL Analysis
5.2.1 Political Landscape5.2.2 Economic Landscape5.2.3 Social Landscape5.2.4 Technological Landscape5.2.5 Environmental Landscape5.2.6 Legal Landscape
5.3 PORTER’s Five Forces5.4 Heat Map Analysis
6. Competitive Landscape
6.1. Global Syringes and Injectable Drugs Packaging Market Manufacturing Base Distribution, Sales Area, Product Type6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Syringes and Injectable Drugs Packaging Market
7. Global Syringes and Injectable Drugs Packaging Market, By Product Type, (USD Million) 2021-2034
7.1 Syringes
7.1.1 Prefilled syringes7.1.2 Conventional syringes
7.2 Injectable drugs packaging
7.2.1 Vials7.2.2 Ampoules7.2.3 Cartridges7.2.4 Bottles
8. Global Syringes and Injectable Drugs Packaging Market, By Material Type, (USD Million) 2021-2034
8.1 Plastic
8.1.1 Polypropylene (PP)8.1.2 Polyethylene (PE)8.1.3 Polycarbonate (PC)8.1.4 Others
8.2 Glass8.3 Others
9. Global Syringes and Injectable Drugs Packaging Market, By End Use, (USD Million) 2021-2034
9.1 Hospitals and clinics9.2 Ambulatory surgical centres (ASCs)9.3 Pharmaceutical & biotechnology companies9.4 Home healthcare settings9.5 Vaccination centres
10. Global Syringes and Injectable Drugs Packaging Market, (USD Million) 2021-2034
10.1 Global Syringes and Injectable Drugs Packaging Market Size and Market Share
11. Global Syringes and Injectable Drugs Packaging Market, By Region, 2021-2034 (USD Million)
11.1 Asia-Pacific
11.1.1 Australia11.1.2 China11.1.3 India11.1.4 Japan11.1.5 South Korea11.1.6 Rest of Asia-Pacific
11.2 Europe
11.2.1 France11.2.2 Germany11.2.3 Italy11.2.4 Spain11.2.5 United Kingdom11.2.6 Rest of Europe
11.3 Middle East and Africa
11.3.1 Kingdom of Saudi Arabia11.3.2 United Arab Emirates11.3.3 Qatar11.3.4 South Africa11.3.5 Egypt11.3.6 Morocco11.3.7 Nigeria11.3.8 Rest of Middle-East and Africa
11.4 North America
11.4.1 Canada11.4.2 Mexico11.4.3 United States11.4.4 Rest of North America
11.5 Latin America
11.5.1 Argentina11.5.2 Brazil11.5.3 Rest of Latin America
12. Company Profile
12.1 BD
12.1.1 Company details12.1.2 Financial outlook12.1.3 Product summary12.1.4 Recent developments
12.2 AptarGroup Inc.
12.2.1 Company details12.2.2 Financial outlook12.2.3 Product summary12.2.4 Recent developments
12.3 Bormioli Pharma S.p.A.
12.3.1 Company details12.3.2 Financial outlook12.3.3 Product summary12.3.4 Recent developments
12.4 Catalent Inc
12.4.1 Company details12.4.2 Financial outlook12.4.3 Product summary12.4.4 Recent developments
12.5 Credence MedSystems Inc.
12.5.1 Company details12.5.2 Financial outlook12.5.3 Product summary12.5.4 Recent developments
12.6 DWK Life Sciences
12.6.1 Company details12.6.2 Financial outlook12.6.3 Product summary12.6.4 Recent developments
12.7 Gerresheimer
12.7.1 Company details12.7.2 Financial outlook12.7.3 Product summary12.7.4 Recent developments
12.8 J. Penner Corporation
12.8.1 Company details12.8.2 Financial outlook12.8.3 Product summary12.8.4 Recent developments
12.9 Laboratorios Farmaceuticos Rovi S.A.
12.9.1 Company details12.9.2 Financial outlook12.9.3 Product summary12.9.4 Recent developments
12.10 Nipro Europe Group Companies
12.10.1 Company details12.10.2 Financial outlook12.10.3 Product summary12.10.4 Recent developments
12.11 Schott AG
12.11.1 Company details12.11.2 Financial outlook12.11.3 Product summary12.11.4 Recent developments
12.12 SGD Pharma
12.12.1 Company details12.12.2 Financial outlook12.12.3 Product summary12.12.4 Recent developments
12.13 Shandong Province Medicinal Glass Co. Ltd.
12.13.1 Company details12.13.2 Financial outlook12.13.3 Product summary12.13.4 Recent developments
12.14 Stevanato Group
12.14.1 Company details12.14.2 Financial outlook12.14.3 Product summary12.14.4 Recent developments
12.15 Terumo Europe NV
12.15.1 Company details12.15.2 Financial outlook12.15.3 Product summary12.15.4 Recent developments
12.16 USIN Advance Co. Ltd.
12.16.1 Company details12.16.2 Financial outlook12.16.3 Product summary12.16.4 Recent developments
12.17 Weigao Group
12.17.1 Company details12.17.2 Financial outlook12.17.3 Product summary12.17.4 Recent developments
12.18 West Pharmaceutical Services Inc.
12.18.1 Company details12.18.2 Financial outlook12.18.3 Product summary12.18.4 Recent developments
12.19 Others
13. Conclusion
14. List Of Abbreviations
15. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
